The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-751-013·Announced 2013-07-17

Olympia Pharmacy Recalls Medroxyprogesterone Injection Due to Sterility Concerns

Olympia Pharmacy is recalling Medroxyprogesterone 150 mg/ml Injection because FDA inspections raised concerns about quality control and sterility assurance.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury/property-damage reports or structural defects are rated Severe (4). While no specific injuries are reported in the text, the 'Lack of Assurance of Sterility' for an injectable drug represents a significant risk of serious harm (sepsis, infection), aligning with the Severe criteria for high-risk medical products where the defect is structural/process-related rather than cosmetic.

Plain-English summary

Lowlite Investments, Inc. D/B/A Olympia Pharmacy is recalling Medroxyprogesterone 150 mg/ml Injection. The recall was initiated following FDA inspection findings that resulted in concerns regarding quality control processes and the assurance of sterility for the product.

The affected product is identified by lot code L3727 with an expiration date of 6/1/13. The recall is classified as Class II by the FDA. The product was distributed nationwide and in Puerto Rico.

Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or healthcare provider for further instructions.

The recalled product

Product
Medroxyprogesterone 150 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Manufacturer
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Category
Drug — Injectable Sterile
Hazard
Affected units
1

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • L3727 Exp 6/1/13

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 105 recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 105 products in this recall →

Related recalls

Same manufacturer · Lowlite Investments, Inc. D/B/A Olympia Pharmacy

See all →

Same hazard · sterility

See all →

Similar recalls